The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement

Journal of Bone and Joint Surgery - Series B

Volumn 91, Issue 6, 2009, Pages 776-783

  Rajesparan, K ^a   Biant, L C ^a,b   Ahmad, M ^a   Field, R E ^a  

^a Elective Orthopaedic Centre   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANEXAMIC ACID;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BOLUS INJECTION; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE DRUG DOSE; TOTAL HIP PROSTHESIS;

AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BODY MASS INDEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PREOPERATIVE CARE; SEX FACTORS; TRANEXAMIC ACID; VENOUS THROMBOSIS;

EID: 66349089539     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.91B6.22393     Document Type: Article

References (43)

1. McSwiney MM, O'Farrell D, Joshi GP, McCarroll SM. Blood transfusion in total hip arthroplasty: guidelines to eliminate overtransfusion. Can J Anaesth 1993;40:222-226 (Pubitemid 23139268)
2. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996;348:1055-1060 (Pubitemid 26343599)
3. Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg [Br] 2008;90-B:1128-1136
4. Salido JA, Marin LA, Gomez LA, Zorrilla P, Martinez C. Postoperative haemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg [Am] 2002;84-A:216-220 (Pubitemid 37127482)
5. Hynes MC, Calder P, Rosenfeld P, Scott G. The use of tranexamic acid to reduce blood loss during total hip arthroplasty: an observational study. Ann R Coll Surg Engl 2005;87:99-101. (Pubitemid 40394358)
6. Shore-Lesserson L, Reich DL, Vela-Cantos F, et al. Tranexamic acid reduces transfusions and mediastinal drainage in repeat cardiac surgery. Anesth Analg 1996;83:18-26. (Pubitemid 26225369)
7. Fahmy NR, Patel DG. Hemostatic changes and post-operative deep-vein thrombosis associated with use of a pneumatic tourniquet. J Bone Joint Surg [Am] 1981;63-A:461-465 (Pubitemid 11154154)
8. Dahl OE. The role of pulmonary circulation in the regulation of coagulation and fibrinolysis in relation to major surgery. J Cardiothorac Vasc Anesth 1997;11:322-328 (Pubitemid 27214902)
9. Ekback G, Axelsson K, Ryttberg L, et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 2000;91:1124-1130
10. Hiippala S, Strid L, Wennerstand M, et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 1995;74:534-537
11. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double- blind study of 86 patients. J Bone Joint Surg [Br] 1996;78-B:434-440 (Pubitemid 26158834)
12. Molloy DO, Archbold HA, Ogonda L, et al. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg [Br] 2007;89-B:306-309 (Pubitemid 46563903)
13. Niskanen RO, Korkala OL. Tranexamic acid reduces blood loss in cemented hip arthroplasty. Acta Orthopaedica 2005;76:829-832
14. Husted H, Blond L, Sonne-Holm S, et al. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients. Acta Orthop Scand 2003;74:665-669 (Pubitemid 38067866)
15. Benoni G, Fredin H, Knebel R, Nilsson P. Blood conservation with tranexamic acid in total hip arthroplasty: a randomized double-blind study in 40 primary operations. Acta Orthop Scand 2001;72:442-448 (Pubitemid 33043582)
16. Lemay E, Guay J, Cote C, Roy A. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 2004;51:31-37 (Pubitemid 38351236)
17. Benoni G, Lethagen S, Nilsson P, Fredin H. Tranexamic acid, given at the end of the operation, does not reduce postoperative blood loss in hip arthroplasty. Acta Orthop Scand 2000;71:250-254 (Pubitemid 30648928)
18. Garneti N, Field J. Bone bleeding during total hip arthroplasty after administration of tranexamic acid. J Arthroplasty 2004;19:488-492 (Pubitemid 38725933)
19. Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 2007;107:397-401.
20. Duquenne P, Hoest L, Henkes W, De Sart F. Tranexamic acid reduces postoperative blood losses associated with elective total hip replacement. J Bone Joint Surg [Br] 1999;81-B(Suppl II):233-234
21. Johansson T, Pettersson L-G, Lisander B. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients. Acta Orthopaedica 2005;76:314-319 (Pubitemid 41039344)
22. Krishnamurti C, Vukelja S. Inhibitory effects of lysine analogues on t-PA induced whole clot lysis. Thromb Res 1994;73:419-430 (Pubitemid 24094574)
23. Jansen AJ, Andreica S, Claeys M, et al. Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty. Br J Anaesth 1999;83:596-601. (Pubitemid 29458825)
24. Sano M, Hakusui H, Kojima C, Akimoto T. Absorption and excretion of tranexamic acid following intravenous, intramuscular and oral administrations in healthy volunteers. Jpn J Clin Pharmacol Therapeutics 1976;7:375-381
25. Benoni G, Bjorkman S, Fredin H. Application of pharmacokinetic data from healthy volunteers for the prediction of plasma concentrations of tranexamic acid in surgical patients. Clin Drug Invest 1995;10:280-287
26. Kassis J, Hirsch J, Podor TJ. Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that simulate endothelial cell type I plasminogen activator inhibitor biosynthesis. Blood 1992;80:1758-1764
27. Eriksson B, Hultman E, Martinell S, et al. Regional fibrinolysis following total hip replacement. Thromb Res 1991;62:441-447
28. Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. J Bone Joint Surg [Am] 2005;87-A:766-770 (Pubitemid 40489352)
29. Ido K, Neo M, Asada Y, et al. Reduction of blood loss using tranexamic acid in total knee and hip arthroplasties. Arch Orthop Trauma Surg 2000;120:518-520
30. Yamasaki S, Masuhara K, Fuji T. Tranexamic acid reduces blood loss after cementless total hip arthroplasty: prospective randomized study in 40 cases. Int Orthop 2004;28:69-73. (Pubitemid 38543976)
31. Eriksson BI, Borris LC, Friedman RJ, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008;358:2765-2775
32. Kakkar AK, Brenner B, Dahl OE, et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet 2008;372:31-39
33. Lassen MR, Ageno W, Borris LC, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008;358:2776-2786
34. Eriksson BI, Kakkar AK, Turpie AGG, et al. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacements. J Bone Joint Surg [Br] 2009;91-B:636-644
35. Lemmens H, Bernstein D, Brodsky J. Estimating blood volume in obese and morbidly obese patients. Obes Surg 2006;16:773-776 (Pubitemid 43874836)
36. Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology 1983;58:277-280
37. Flordal PA. Measurement of blood loss in clinical studies. Eur J Anaesthesiol Suppl 1997;14:35-37 (Pubitemid 27491337)
38. Thorsson O, Leander P, Lilja B, et al. Comparing ultrasonography, magnetic resonance imaging and scintigraphy in evaluating an experimentally-induced hematoma. Scand J Med Sci Sports 1993;3:110-116 (Pubitemid 23286330)
39. Grosflam JM, Wright EA, Cleary PD, Katz JN. Predictors of blood loss during total hip replacement surgery. Arthritis Care Res 1995;8:167-173
40. Cushner FD, Friedman RJ. Blood loss in total knee arthroplasty. Clin Orthop 1991;269:98-101.
41. Prasad N, Padmanabhan V, Mullaji A. Blood loss in total knee arthroplasty: an analysis of risk factors. Int Orthop 2007;31:39-44. (Pubitemid 46208221)
42. Trice ME, Walker RH, D'Lima DD, Morris BA, Colwell CW Jr. Blood loss and transfusion rate in noncemented and cemented/hybrid total hip arthroplasty: is there a difference?: a comparison of 25 matched pairs. Orthopedics 1999;22:141-144
43. No authors listed. The national joint registry. http://www.njrcentre.org. uk (date last accessed 27 April 2009).